Skip navigation

ISOS

Summary

Chronic diseases, demanding lengthy treatments, often push patients into inconvenience and discomfort. Repetitive intrusions of therapies for conditions like age-related macular degeneration, inflammatory bowel diseases or cancer not only disrupt lives but also risk side effects. The EIC-funded ISOS project aims to revolutionise healthcare with a pioneering biomedical solution. By seamlessly integrating genetically engineered bacteria into a biomaterial-based bioreactor, ISOS presents a visionary approach to in situ, on-demand fabrication and auto-renewed delivery of therapeutic compounds based on dynamic variation of pathological signals. In silico simulations allow modelling interactions between bacteria, biomolecules, cells, and tissues/organs, and define optimal microbiota ecosystems to treat the pathology with the best efficacy. The ISOS initiative holds the promise of transforming prolonged treatments into personalised, efficient, and minimally invasive healthcare experiences.

 

ISOS picture 

Northumbria investigators 

Prof Meng Zhang and Dr Paul James

 

 

Partners

SILK BIOMED, S.L. ES 

UNIVERSIDAD COMPLUTENSE DE MADRID ES 

UNIVERSITAET LEIPZIG DE 

FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANG DE 

Alien tt Italy SRL Italy 

 

 

Funder

European Union, Horizon Europe, EIC Pathfinder Open; Grant Agreement ID: 101130454

 

 

Duration

3 years (1 December 2023- 30 November 2026)


Latest News and Features

two men collecting plastic to be recycled
UUK 50 Future Innovators
an image of a plane wing during a flight with icy ground below
Northumbria University graduate and Founder of Cricketqube Initiative CIC, Alosh K Jose
Glasgow sky
students at orbyts event
holding hands, old person and young person
Northumbria Business School
More events

Upcoming events

Snow Problem? Why Arctic Snow Matters in a Warming World
Northumbria University Carol Service 2026
Back to top